Physician profile
Brian Dessify
NPI 1780063974
$18,273.65
in general payments reported to CMS, 2019-2025
17 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $395 · 2021: $169 · 2022: $388 · 2023: $409 · 2024: $17K · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $16K · Food and Beverage: $1,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $16,000.00 |
| Food and Beverage | $1,321.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,189.56 | 2022-2025 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $332.00 | 2019 | |
| Ethicon US, LLC | $179.27 | 2022-2025 | Echelon Circular, Enseal, Echelon Endopath |
| Ethicon Endo-Surgery INC. | $131.68 | 2023 | Harmonic |
| Regeneron Healthcare Solutions, INC. | $123.97 | 2021 | |
| Reddress USA, INC. | $51.68 | 2021-2022 | |
| Csl Behring | $43.43 | 2019 | |
| Davol INC. | $33.68 | 2024 | Phasix Mesh |
| Tela Bio, INC. | $32.48 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $29.89 | 2024 | Progrip |
| Kerecis Limited | $25.52 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Teleflex LLC | $20.31 | 2023 | Titan Sgs Standard Gastric Stapler |
| Acelrx Pharmaceuticals, INC. | $19.80 | 2019 | |
| Enterra Medical, INC. | $18.07 | 2023 | |
| Endo Pharmaceuticals INC. | $14.37 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $14.00 | 2022 | |
| Standard Bariatrics, INC. | $13.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Dessify listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.